UK-London-Metro Enterprise North
GBR-ALPHA-01Tier-1 sovereign territory spanning Greater London financial core, Shoreditch tech corridor, and Canary Wharf logistics hub.
Across 42 Tier-1 Enterprise Accounts
$18.2M actual / $21.5M sovereign target
14 Field Reps Active0 SLA Breaches
Territory Commercial Funnel
Drill into SG-04 Leadsopen_in_new
Explore SG-06 Dealsopen_in_new
Weighted Forecast: $16.89M
Key Accounts in Territory
Gogidix anchors driving >60% of territory billings
| Account Dossier | Industry Tier | Pipeline ARR | Account Lead | Contract Status | Action |
|---|---|---|---|---|---|
BP Barclays PLC ACC-UK-0912 • 1 Churchill Place | Global FinServ | $8,400,000 | EMElena Mikhailov | Active Renewal | |
BP BP International ACC-UK-0441 • St James's Square | Energy & Transition | $6,150,000 | DKDavid Kerr | Expansion P3 | |
AZ AstraZeneca UK ACC-UK-8821 • 1 Francis Crick Ave | Pharma & BioTech | $5,400,000 | SOSarah O'Connor | Procurement | |
LS London Stock Exchange Group ACC-UK-1094 • 10 Paternoster Sq | Financial Infrastructure | $4,900,000 | AHAlistair Hayes | MSA Enforced |
Territory Boundary Geometry
Canary Wharf • City Core • Shoreditch Corridor
badgeTerritory Leadership
LID-GB-401
Alistair Hayes
verifiedTerritory Sales Director
a.hayes@gogidix.co.uk
Lineage & Provenance
Territory Re-alignment Approved
Auth: VP Sales EMEA • Ref #REQ-9921
Q3 Quota Baseline Published
$21.50M Target set via territory-management-service
Account Reallocation: AstraZeneca
Transferred from UK-South to UK-London-Metro
Territory exhibits 94% closing probability for Q3 targets based on Barclays PLC expansion timeline and rep deployment saturation.
